#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	14148	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2175	646.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1412	1412	C	828	C	784	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25854	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3590	717.9	0	.	n	.	0	T695C	SNP	695	695	T	1030	1030	C	832	C,T	765,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25854	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3590	717.9	0	.	n	.	0	G1337A	SNP	1337	1337	G	1672	1672	A	827	A,G,T	782,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25854	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3590	717.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2306	2306	C	838	C	779	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25854	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3590	717.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2380	2380	A	816	A	774	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25854	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3590	717.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	2932	2932	C	847	C	795	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	27	1886	folP	852	852	100.0	folP.l15.c4.ctg.1	1664	113.0	1	SNP	p	R228S	0	.	.	682	684	CGC	1135	1137	CGC	214;215;215	C;G;C	191;196;193	folP.WHO_F_01537c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	4994	gyrA	2751	2751	99.78	gyrA.l6.c4.ctg.1	3359	148.1	0	.	p	.	0	T243I	NONSYN	727	729	ACA	1049	1051	ATA	155;153;153	A;T;A	148;143;145	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	4994	gyrA	2751	2751	99.78	gyrA.l6.c4.ctg.1	3359	148.1	0	.	p	.	0	M250I	NONSYN	748	750	ATG	1070	1072	ATA	150;153;152	A;T;A	138;144;140	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	4994	gyrA	2751	2751	99.78	gyrA.l6.c4.ctg.1	3359	148.1	1	SNP	p	S91F	0	.	.	271	273	TCC	593	595	TCC	179;176;176	T;C;C	170;167;168	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	4994	gyrA	2751	2751	99.78	gyrA.l6.c4.ctg.1	3359	148.1	1	SNP	p	D95G	0	.	.	283	285	GAC	605	607	GAC	172;172;172	G;A;C	166;164;165	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	4994	gyrA	2751	2751	99.78	gyrA.l6.c4.ctg.1	3359	148.1	1	SNP	p	D95N	0	.	.	283	285	GAC	605	607	GAC	172;172;172	G;A;C	166;164;165	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	539	1568	mtrR	633	633	99.68	mtrR.l6.c30.ctg.1	1292	121.0	0	.	p	.	0	S32W	NONSYN	94	96	TCG	441	443	TGG	171;171;171	T;G;G	163;166;165	.	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	539	1568	mtrR	633	633	99.68	mtrR.l6.c30.ctg.1	1292	121.0	0	.	p	.	0	D79N	NONSYN	235	237	GAT	582	584	AAT	207;206;201	A;A;T	189;191;181	.	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	539	1568	mtrR	633	633	99.68	mtrR.l6.c30.ctg.1	1292	121.0	1	SNP	p	G45D	0	.	.	133	135	GGC	480	482	GGC	181;182;182	G;G;C	175;175;174	mtrR.WHO_U_01459:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	910	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1114	81.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	4852	parC	2304	2304	99.83	parC.l15.c4.ctg.1	2965	163.2	1	SNP	p	D86N	0	.	.	256	258	GAC	589	591	GAC	210;211;210	G;A;C	198;195;194	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	4852	parC	2304	2304	99.83	parC.l15.c4.ctg.1	2965	163.2	1	SNP	p	S88P	0	.	.	262	264	TCC	595	597	TCC	206;205;206	TCC,TC;C;C	195,1;189;189	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4070	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2627	154.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1568	1570	GGC	234;230;228	G;G;C	215;210;204	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	539	3892	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2285	169.1	0	.	p	.	0	R213W	NONSYN	637	639	CGG	918	920	TGG	181;180;182	T;G;G	172;171;174	.	.
penA.9.001	penA.9.001	1	1	539	3892	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2285	169.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1212	1214	GCA	231;233;234	G;C,A;A	212;215,1;219	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	3892	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2285	169.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1215	1217	ATC	234;231;233	A;T;C	217;216;215	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	3892	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2285	169.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1227	1229	GTG	244;247;248	G;T;G	231;231;234	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	3892	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2285	169.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1227	1229	GTG	244;247;248	G;T;G	231;231;234	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	3892	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2285	169.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1731	1733	ACC	205;206;207	A;C;C	183;183;186	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	3892	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2285	169.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1785	1787	GCG	196;194;192	G,C;C;G	168,1;157;160	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	3892	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2285	169.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1785	1787	GCG	196;194;192	G,C;C;G	168,1;157;160	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	3892	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2285	169.1	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1908	1910	GGC	152;150;148	G;G;C	140;138;141	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	3892	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2285	169.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1917	1919	GGC	145;145;144	G;G;C	132;134;134	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	3892	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2285	169.1	1	SNP	p	L552S	0	.	.	1654	1656	CTG	1935	1937	CTG	138;138;133	C,G;T;G	104,6;88;99	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5600	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3205	174.5	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1692	1694	CCG	185;183;182	C;C,T;G	157;165,1;163	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2114	porA	1146	1146	99.83	porA.l15.c30.ctg.1	1770	118.8	0	.	p	.	0	S22G	NONSYN	64	66	AGC	434	436	GGC	151;149;151	G;G;C	137;136;139	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2114	porA	1146	1146	99.83	porA.l15.c30.ctg.1	1770	118.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	616	616	C	152	C	137	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2840	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1653	171.1	0	.	p	.	0	E48G	NONSYN	142	144	GAA	608	610	GGA	223;221;222	G;G;A	205;203;202	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2840	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1653	171.1	0	.	p	.	0	V75I	NONSYN	223	225	GTT	689	691	ATT	251;252;256	A;T;T,A	233;235;235,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2840	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1653	171.1	0	.	p	.	0	T89S	NONSYN	265	267	ACC	731	733	AGC	234;234;235	A;G;C	215;219;221	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2840	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1653	171.1	0	.	p	.	0	V98I	NONSYN	292	294	GTC	758	760	ATC	228;227;221	A;T;C,A	214;213;211,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2840	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1653	171.1	0	.	p	.	0	.	MULTIPLE	358	359	AA	823	824	CG	199;201	C;G,A	182;177,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2840	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1653	171.1	0	.	p	.	0	.	MULTIPLE	361	362	GA	826	828	CAG	199;199;201	C,G;A;G,A	182,1;183;181,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2840	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1653	171.1	0	.	p	.	0	N122K	NONSYN	364	366	AAC	830	832	AAA	204;207;205	A;A;A,C	186;195;192,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2840	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1653	171.1	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	857	859	TAT	198;200;205	T;A,T;T	188;187,2;189	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2840	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1653	171.1	0	.	p	.	0	N134E	NONSYN	400	402	AAT	866	868	GAG	199;197;197	G,A;A;G,T	188,1;186;186,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2840	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1653	171.1	0	.	p	.	0	V135L	NONSYN	403	405	GTG	869	871	CTT	194;193;197	C,G;T;T,G	182,1;183;188,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2840	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1653	171.1	0	.	p	.	0	G140K	NONSYN	418	420	GGA	884	886	AAA	201;203;207	A,G;A,G;A	192,1;195,1;199	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2840	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1653	171.1	0	.	p	.	0	K143E	NONSYN	427	429	AAA	893	895	GAA	212;211;212	G,C;A;A	198,2;201;199	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2840	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1653	171.1	0	.	p	.	0	V151A	NONSYN	451	453	GTA	917	919	GCA	229;235;238	G;C,T,A;A	212;216,2,1;220	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2840	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1653	171.1	0	.	p	.	0	T213S	NONSYN	637	639	ACA	1103	1105	TCA	241;244;243	T,G;C;A	227,1;234;231	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2840	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1653	171.1	0	.	p	.	0	G253Q	NONSYN	757	759	GGA	1223	1225	CAA	196;196;195	C;A;A	188;188;188	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2840	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1653	171.1	0	.	p	.	0	.	INDELS	760	762	ACA	1227	1231	ATCAA	192;192;193;192;194	A;T;C;A;A	185;187;187;188;191	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2840	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1653	171.1	0	.	p	.	0	.	INDELS	763	764	TG	1234	1236	AGT	194;192;190	A;G;T	190;188;184	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2840	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1653	171.1	0	.	p	.	0	A257D	NONSYN	769	771	GCT	1241	1243	GAT	200;204;208	G;A;T	193;196;200	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2840	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1653	171.1	0	.	p	.	0	D293S	NONSYN	877	879	GAT	1349	1351	AGT	250;249;249	A;G;T,C	231;227;222,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2840	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1653	171.1	0	.	p	.	0	N295D	NONSYN	883	885	AAC	1355	1357	GAC	244;243;242	G;A;C	227;227;224	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2840	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1653	171.1	0	.	p	.	0	H296Y	NONSYN	886	888	CAC	1358	1360	TAC	241;242;242	T;A;C	224;225;228	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2840	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1653	171.1	1	SNP	p	G120K	1	.	.	358	360	AAG	823	825	CGG	199;201;200	C;G,A;G,A	182;177,1;181,1	porB1b.WHO_M_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2840	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1653	171.1	1	SNP	p	D121N	0	.	.	361	363	GAC	826	829	CGC	199;201;203	C,G;G,A;C	182,1;181,1;186	porB1b.WHO_M_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2840	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1653	171.1	1	SNP	p	A121D	1	.	.	361	363	GAC	826	829	CGC	199;201;203	C,G;G,A;C	182,1;181,1;186	porB1b.WHO_M_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10420	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	4958	209.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1080	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1070	100.6	1	SNP	p	V57M	1	.	.	169	171	ATG	578	580	ATG	215;216;213	A;T;G	204;204;204	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8358	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2644	315.2	0	.	p	.	0	M177T	NONSYN	529	531	ATG	933	935	ACG	315;317;313	A;C,T;G	304;306,1;306	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8358	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2644	315.2	0	.	p	.	0	Y184D	NONSYN	550	552	TAC	954	956	GAC	275;275;279	G;A;C	275;271;278	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8358	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2644	315.2	0	.	p	.	0	T190M	NONSYN	568	570	ACG	972	974	ATG	276;282;282	A;T;G	273;282;280	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8358	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2644	315.2	0	.	p	.	0	L194S	NONSYN	580	582	TTA	984	986	TCA	271;272;269	T;C;A	269;271;269	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8358	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2644	315.2	0	.	p	.	0	H209Q	NONSYN	625	627	CAT	1029	1031	CAG	284;285;285	C;A,T;G	276;277,1;275	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8358	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2644	315.2	0	.	p	.	0	V216L	NONSYN	646	648	GTT	1050	1052	CTT	287;286;284	C;T;T	281;280;281	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8358	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2644	315.2	0	.	p	.	0	N223S	NONSYN	667	669	AAC	1071	1073	AGT	280;282;280	A;G;T	275;275;266	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8358	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2644	315.2	0	.	p	.	0	Q246P	NONSYN	736	738	CAG	1140	1142	CCG	399;404;405	C;C;G	372;377;379	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8358	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2644	315.2	0	.	p	.	0	P280S	NONSYN	838	840	CCG	1242	1244	TCG	447;446;441	T;C;G	417;415;412	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8358	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2644	315.2	0	.	p	.	0	E337K	NONSYN	1009	1011	GAG	1413	1415	AAA	235;229;227	A;A;A	226;222;221	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8358	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2644	315.2	0	.	p	.	0	R338K	NONSYN	1012	1014	AGA	1416	1418	AAG	227;223;219	A;A;G	222;218;215	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8358	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2644	315.2	0	.	p	.	0	L343H	NONSYN	1027	1029	CTC	1431	1433	CAC	191;187;188	C;A;C	189;179;188	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8358	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2644	315.2	0	.	p	.	0	Q356E	NONSYN	1066	1068	CAA	1470	1472	GAA	171;172;171	G;A;A	169;168;170	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8358	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2644	315.2	0	.	p	.	0	A382T	NONSYN	1144	1146	GCG	1548	1550	ACG	141;139;132	A;C;G	139;136;130	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8358	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2644	315.2	0	.	p	.	0	T399I	NONSYN	1195	1197	ACT	1599	1601	ATT	182;185;186	A;T;T	173;175;177	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8358	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2644	315.2	0	.	p	.	0	C400S	NONSYN	1198	1200	TGT	1602	1604	AGT	184;185;183	A;G;T	174;175;172	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8358	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2644	315.2	0	.	p	.	0	I413L	NONSYN	1237	1239	ATA	1641	1643	CTA	207;209;209	C;T;A	195;198;198	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8358	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2644	315.2	0	.	p	.	0	K427N	NONSYN	1279	1281	AAA	1683	1685	AAT	155;154;155	A;A;T	151;150;150	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8358	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2644	315.2	0	.	p	.	0	A450S	NONSYN	1348	1350	GCA	1752	1754	TCA	240;238;240	T;C;A	232;229;231	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8358	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2644	315.2	0	.	p	.	0	V458M	NONSYN	1372	1374	GTA	1776	1778	ATG	246;246;250	A;T;G	238;238;242	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8358	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2644	315.2	0	.	p	.	0	N556T	NONSYN	1666	1668	AAC	2070	2072	ACC	447;449;446	A;C;C	423;425;423	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8358	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2644	315.2	0	.	p	.	0	K588E	NONSYN	1762	1764	AAA	2166	2168	GAA	475;474;476	G;A;A	443;442;440	.	Tetracycline resistance
